Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 353

Related Citations for PubMed (Select 17646204)

1.
2.

Re: "invited commentary: Hormone therapy and risk of coronary heart disease-why renew the focus on the early years of menopause?".

Rosenberg L.

Am J Epidemiol. 2007 Dec 15;166(12):1480-1; author reply 1481-2. Epub 2007 Nov 10. No abstract available.

3.

Re: "invited commentary: Hormone therapy and risk of coronary heart disease--why renew the focus on the early years of menopause?".

Dören M, Greiser EM.

Am J Epidemiol. 2007 Dec 15;166(12):1479-80; author reply 1481-2. Epub 2007 Oct 31. No abstract available.

4.

Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

Banks E, Canfell K.

Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25.

6.

Hormones and heart disease in women: the timing hypothesis.

Barrett-Connor E.

Am J Epidemiol. 2007 Sep 1;166(5):506-10.

7.

Menopausal hormone therapy.

Bhavnani BR, Strickler RC.

J Obstet Gynaecol Can. 2005 Feb;27(2):137-62. Review.

PMID:
15937590
8.

Hormone therapy: evolving concepts.

Hendrix SL.

Curr Opin Rheumatol. 2003 Jul;15(4):464-8. Review.

PMID:
12819476
9.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
10.

KEEPS: The Kronos Early Estrogen Prevention Study.

Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N.

Climacteric. 2005 Mar;8(1):3-12.

PMID:
15804727
11.
12.

Estrogen with and without progestin: benefits and risks of short-term use.

LaCroix AZ.

Am J Med. 2005 Dec 19;118 Suppl 12B:79-87.

PMID:
16414331
13.

Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.

Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.

J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):85-92. doi: 10.2459/JCM.0b013e328313e979.

PMID:
19145119
14.

Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.

Harman SM, Naftolin F, Brinton EA, Judelson DR.

Ann N Y Acad Sci. 2005 Jun;1052:43-56.

PMID:
16024750
15.

Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.

Grodstein F, Manson JE, Stampfer MJ.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):35-44.

PMID:
16417416
16.
17.

[Postmenopausal hormone-replacement therapy discredited, except in healthy women shortly after menopause].

Maas AH, van der Graaf Y.

Ned Tijdschr Geneeskd. 2002 Nov 9;146(45):2127-30. Dutch.

PMID:
12474550
18.

On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.

Langer RD.

Climacteric. 2010 Aug;13(4):303-6. doi: 10.3109/13697137.2010.496316.

PMID:
20540591
19.

[Menopausal hormone therapy and cardiovascular disease].

Wenger NK.

Rev Esp Cardiol. 2006 Oct;59(10):1058-69. Review. Spanish.

20.

Coronary heart disease and menopause management: the swinging pendulum of HRT.

Stevenson JC, Hodis HN, Pickar JH, Lobo RA.

Atherosclerosis. 2009 Dec;207(2):336-40. doi: 10.1016/j.atherosclerosis.2009.05.033. Epub 2009 Jun 6. Review.

PMID:
19560146
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk